Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Which Instax Camera Would it be a good idea for you to Purchase? - 2Focus on Yourself: Wellbeing and Taking care of oneself Practices
- 3Single women risk rape and exploitation in search for better life in Europe
- 4Which Startup's Innovation Could Reform Medical care?
- 5Well known Travel Booking Locales: What's Your Pick?
- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- Living Abroad: Social Inundation and Self-improvement
- Grasping the Commencement of Criminal Cases: An Extensive Outline
- From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
- Picking Childcare Administrations for Your Loved ones
- Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
- Sound and Delightful: 12 Nutritious Smoothie Recipes
- Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- The Best Internet Mastering Stages for Expertise Improvement
